Spots Global Cancer Trial Database for human papilloma virus (hpv)
Every month we try and update this database with for human papilloma virus (hpv) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Avelumab for People With Recurrent Respiratory Papillomatosis | NCT02859454 | Recurrent Respi... Juvenile Laryng... Laryngeal Papil... Respiratory Pap... Human Papilloma... | Avelumab | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
Human Papillomavirus and Cervical Dysplasia in Women With Cystic Fibrosis | NCT03052556 | Cystic Fibrosis | Pap smear test ... | 18 Years - | Hospices Civils de Lyon | |
Evaluation of Oral EGCG Treatment for L-SIL Associated With HPV Infection | NCT06314113 | Low-Grade Intra... | Epigallocatechi... | 18 Years - 65 Years | University of Palermo | |
An Innovative Treatment for Cervical Precancer (UH3) | NCT03084081 | Cervical Intrae... | CO2 standard th... CryoPen Thermocoagulato... | 18 Years - 65 Years | The Cleveland Clinic | |
Low-Cost Molecular Cervical Cancer Screening Study | NCT01231945 | DNA Probes E6 Protein Uterine Cervica... HPV | 25 Years - 65 Years | National Institutes of Health Clinical Center (CC) | ||
Low-Cost Molecular Cervical Cancer Screening Study | NCT01231945 | DNA Probes E6 Protein Uterine Cervica... HPV | 25 Years - 65 Years | National Institutes of Health Clinical Center (CC) | ||
A Comparison Study of Two Community Outreach-Based Approaches to Increase Participation of Women Living in the Mississippi Delta in Cervical Cancer Screening | NCT01058148 | Cervical Intrae... Human Papilloma... | 26 Years - 65 Years | National Institutes of Health Clinical Center (CC) | ||
INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP) | NCT04398433 | Respiratory Pap... | INO-3107 CELLECTRA™ 2000 | 18 Years - | Inovio Pharmaceuticals | |
Evaluation of the Cobas® 4800 HPV Test for the Detection of High-grade Cervical Disease | NCT00709891 | Human Papilloma... | cobas® 4800 HPV... | 21 Years - | Hoffmann-La Roche | |
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts | NCT03981822 | Condylomata Acu... Papillomavirus ... Skin Diseases, ... Skin Diseases, ... Skin Diseases Sexually Transm... Sexually Transm... Warts | VP-102 and appl... Placebo | 18 Years - | Verrica Pharmaceuticals Inc. | |
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts | NCT03981822 | Condylomata Acu... Papillomavirus ... Skin Diseases, ... Skin Diseases, ... Skin Diseases Sexually Transm... Sexually Transm... Warts | VP-102 and appl... Placebo | 18 Years - | Verrica Pharmaceuticals Inc. | |
A Comparison Study of Two Community Outreach-Based Approaches to Increase Participation of Women Living in the Mississippi Delta in Cervical Cancer Screening | NCT01058148 | Cervical Intrae... Human Papilloma... | 26 Years - 65 Years | National Institutes of Health Clinical Center (CC) | ||
INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP) | NCT04398433 | Respiratory Pap... | INO-3107 CELLECTRA™ 2000 | 18 Years - | Inovio Pharmaceuticals | |
Avelumab for People With Recurrent Respiratory Papillomatosis | NCT02859454 | Recurrent Respi... Juvenile Laryng... Laryngeal Papil... Respiratory Pap... Human Papilloma... | Avelumab | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts | NCT03981822 | Condylomata Acu... Papillomavirus ... Skin Diseases, ... Skin Diseases, ... Skin Diseases Sexually Transm... Sexually Transm... Warts | VP-102 and appl... Placebo | 18 Years - | Verrica Pharmaceuticals Inc. |